Skip Navigation

British Journal of Anaesthesia 2006 97(4):580-582; doi:10.1093/bja/ael228
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Albaladejo, P.
Right arrow Articles by Samama, C.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albaladejo, P.
Right arrow Articles by Samama, C.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force

The first 10% of the full text of this article appears below.

Editor—Following recent articles relating to perioperative antiplatelet drugs (APs) in the British Journal of Anaesthesia,13 we thought it would be of interest to share with you the recommendations of a recent working party in France which addressed the use of APs in patients with coronary stents.

Currently, high-level evidence is lacking in the literature in support for strong recommendations on the perioperative use of APs. The lack of evidence is particularly striking when considering patients with coronary stents, especially drug-eluting stents. This is a problem because an increasing number of patients with stents and receiving a combination of APs (aspirin and clopidogrel) . . . [Full Text of this Article]

Recommendations

Task Force: members

P. Albaladejo1, E. Marret1, V. Piriou2 and C.-M. Samama, (working group chair)1,*

1 Paris, France
2 Lyon, France

*E-mail: marc.samama@htd.aphp.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
M Luckie, R S Khattar, and D Fraser
Non-cardiac surgery and antiplatelet therapy following coronary artery stenting
Heart, August 15, 2009; 95(16): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Evans and R. G. Davies
A new type of coronary artery stent
Br. J. Anaesth., March 1, 2009; 102(3): 435 - 436.
[Full Text] [PDF]


Home page
BMJHome page
N. L M Cruden, S. A Harding, and D. E Newby
Coronary stent thrombosis in the perioperative period
BMJ, November 24, 2008; 337(nov24_1): a2074 - a2074.
[Full Text]


Home page
Anesth. Analg.Home page
L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster
Coronary Artery Stents: II. Perioperative Considerations and Management
Anesth. Analg., August 1, 2008; 107(2): 570 - 590.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
G. Godet, Y. Le Manach, F. Lesache, S. Perbet, and P. Coriat
Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?
Br. J. Anaesth., April 1, 2008; 100(4): 472 - 477.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. E. Bertrand
When and how to discontinue antiplatelet therapy
Eur. Heart J. Suppl., January 1, 2008; 10(suppl_A): A35 - A41.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574.
[Abstract] [Full Text] [PDF]